Enosium Life Science
.jpg)
Founded in 2024, Enosium Life Science brings together specialized scientific service providers supporting the healthcare and life sciences industries across Europe. The platform acquires majority ownership in expert firms covering clinical research, regulatory affairs, market access, medical affairs, and healthcare marketing, while allowing existing teams to continue serving their clients independently. Companies that join the platform benefit from shared resources in business development, talent management, digital tools, and operational support, enabling them to scale their impact and become long-term partners to leading health industry players.
Build a leading European scientific services group by bringing together independent experts across the healthcare and life sciences value chain, from clinical development to market access and commercialization.
Providing independent life sciences service companies with the scale, structure and access they need to grow in a globalised sector where specialised players face limited visibility, competition from generalist consulting firms, recruitment challenges and difficulties in reaching global pharmaceutical decision-makers, despite growing demand for integrated and cross-functional solutions.
Key Figures
Why we invested
The life sciences consulting and outsourced services market is a large, fast-growing and increasingly strategic global industry, estimated at €35 billion and expanding at 10–14%. This growth is driven by the rising share of biotech in drug innovation and the continued outsourcing of high-value functions by pharmaceutical companies, particularly in regulatory, clinical, market access, and medical affairs. Despite strong demand, the market remains highly fragmented, with many specialized firms facing structural challenges: limited visibility, difficulty accessing global decision-makers, and growing competition from generalist consulting firms. These dynamics, along with proven consolidation playbooks in the US and UK, reinforce our belief that there is a unique opportunity to build a leading European platform in scientific services for the health industry.
